Elocon
Elocon

33.3
For patients managing skin conditions, this generic medicine reduces redness, swelling, and itching through targeted inflammatory response modulation.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Mometasone furoate
Reference Brand
Mometasone furoate
Product Origin
Generic Alternative
Reference Manufacturer
Schering-Plough
Product Form
Ointment
Regulatory Classification
Prescription Only Medicine
Primary Category
Skin Care
Product Category
Glucocorticoid
Pharmacological Class
Topical Corticosteroid
Clinical Indications
Manufacturer Description
Formulated to alleviate local skin inflammation to support epidermal healing and target dermal irritation.
Mechanism of Action
Suppresses transcription of leukocyte inflammatory cytokines and arachidonic acid synthesis inside structural skin tissue cells.
Route of Administration
Topical
Onset Time
1–3 days
Duration
12–24 hours
Contraindications
Untreated cutaneous fungal or viral infections
Severe Adverse Events
Adrenal suppression — requires immediate medical attention
Common Side Effects
Local burning, Erythema
Uncommon Side Effects
Skin thinning, Mild striae, Pruritus
Pregnancy Safety Warnings
TGA Category C: Minimal systemic absorption. Use if benefit justifies risk. Breastfeeding: Compatible.
Age Restrictions
Approved for children over two years and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Elocon is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to access OCP Medication Online - Levonorgestrel Emergency Contraception